PharmaClick’s Post

📰 ✨✔We are thrilled to announce the publication of our latest article 'Oromucosal spray products – Viscosity impact on spray performance evaluation' in the Journal of Drug Delivery Science and Technology. 🔬This research aims to highlight the significance of investigating quality attributes and their impact on spray performance from the initial stages of development. 👩🔬The authors of this research paper are Francisca Bastos Silva, Andreia Tabanez, Maria Aquino, Antonio Lucas Nunes and Sergio Simoes. 👉 Follow the link to see this work: https://lnkd.in/dTjf2qjM  #witheyesetonthefuture #followbluepharma #Bluepharma #Bluepharma23anos #Bluepharmaacelera2030 #pharmaceuticalindustry #pharmaceutical #industry #indústriafarmacêutica #innovation #development #technology #health #pharmaceuticals #generics #CRDMO #CDMO #CMO #complexinjectabels  #highpotentproducts #Pharma #lifescience #oncology #research #pharma

Knowledge is Power' PharmaClick recognises this, and is once again at your service.   'Pharma Quick', an initiative by PharmaClick, is your daily dose of Industry Specific & Business critical News at the ease of your fingertips.   Get ready to be at the forefront of industry trends with Pharma Quick.   Stay informed, Stay Ahead!!   Download the App today for a detailed Read.   Available on play store and app store.     #PharmaClick #pharma #Pharmablogs #blogs #pharmacology #pharmaceuticals #pharmacystudents #pharmaprofessionals #pharmaindustry #marketplace #PharmaApp #Appforpharma #healthcare #health #biotechnology #pharmajobs #pharmaceuticalindustry #USFDA GSK ViiV Healthcare Pfizer BioNTech SE Altimmune, Inc. Cordance Medical Eli Lilly and Company Muscular Dystrophy Association Exatech Tenaya Therapeutics Paige Abbott Roche

Medialis Ltd’ research and observations in #medicalaffairs have guided our development of this Patient-centred pathway implementation method which demonstrates how to introduce a new treatment option into an existing treatment pathway. All new treatments will require some form of integration into current practice. Our structured approach, utilizing our proprietary tools, can give you the best opportunity of enhancing adoption of your new medicine, at a centre-level, after approval. Get in touch at [email protected] #medicine #development  #quality #research #medicalaffairs #rarediseases #strategy #planning #pharmaceutical #medical #communication #design #pharmaceuticalindustry #health #pharma #biopharma #pharmaceutical #pharmaceuticals #oncology #medicine #team #health #research #publications #brand #strategy #planning Avadel Pharmaceuticals plc, Axsome Therapeutics, Inc., Bausch Lomb AOP Health, Bayer, Bazell Pharma, Tillotts Pharma AG, BeiGene Angelini Pharma Nordics, Servier LifeWell Pharmaceutical & Healthcare, Bellerophon Therapeutics, BioCryst Pharmaceuticals, Inc. Acadia Pharmaceuticals Inc., BIOGENERA SpA, BioMarin Pharmaceutical Inc., BioMed Valley Discoveries, Inc., Biosight Ltd., Biotest AG, Birdie, SK Biopharmaceuticals, bluebird bio, Blueprint Medicines, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb Bristol Laboratories Ltd. Caelum Biosciences, Calliditas Therapeutics, Camurus, Can Fite BioPharma (CANFY), BIOPHARMA, Capricor Therapeutics, Inc., Cara Therapeutics, Catalyst Clinical Research, Intercept Pharmaceuticals, Celgene, Biolab Farmacêutica. Biogen

How does prioritizing a quality end product from the outset contribute to effectively managing the journey to commercialization with quality raw materials? Join Randall A. & others for a roundtable discussion on the topic at our Advanced Therapies Roundtable Xchange happening in San Diego, February 29th 2024. To view all facilitators, agendas, registration info and more, please visit: https://lnkd.in/eQAUQU7Y Note: Registration is only open to Senior Scientists and above actively working in the pharmaceutical/biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #drugdiscovery #biotech #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #clinicaldevelopment #clinicalstudies #clinicaltrials #biomarkers #oncology #genomics #pharmaceutical #advancedtherapies #manufacturing #therapeutics #therapies #oligonucleotide #genetherapies

How does prioritizing a quality end product from the outset contribute to effectively managing the journey to commercialization with quality raw materials? Join Randall A. & others for a roundtable discussion on the topic at our Advanced Therapies Roundtable Xchange happening in San Diego, February 29th 2024. To view all facilitators, agendas, registration info and more, please visit: https://lnkd.in/dcuUeiVC Note: Registration is only open to Senior Scientists and above actively working in the pharmaceutical/biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #drugdiscovery #biotech #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #clinicaldevelopment #clinicalstudies #clinicaltrials #biomarkers #oncology #genomics #pharmaceutical #advancedtherapies #manufacturing #therapeutics #therapies #oligonucleotide #genetherapies

How does prioritizing a quality end product from the outset contribute to effectively managing the journey to commercialization with quality raw materials? Join Randall A. & others for a roundtable discussion on the topic at our Advanced Therapies Roundtable Xchange happening in San Diego, February 29th 2024. To view all facilitators, agendas, registration info and more, please visit: https://lnkd.in/exrsm4AC Note: Registration is only open to Senior Scientists and above actively working in the pharmaceutical/biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #drugdiscovery #biotech #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #clinicaldevelopment #clinicalstudies #clinicaltrials #biomarkers #oncology #genomics #pharmaceutical #advancedtherapies #manufacturing #therapeutics #therapies #oligonucleotide #genetherapies

Knowledge is Power' PharmaClick recognises this, and is once again at your service.   'Pharma Quick', an initiative by PharmaClick, is your daily dose of Industry Specific & Business critical News at the ease of your fingertips.   Get ready to be at the forefront of industry trends with Pharma Quick.   Stay informed, Stay Ahead!!   Download the App today for a detailed Read.   Available on play store and app store.       #PharmaClick #pharma #Pharmablogs #blogs #pharmacology #pharmaceuticals #pharmacystudents #pharmaprofessionals #pharmaindustry #marketplace #PharmaApp #Appforpharma #healthcare #health #biotechnology #pharmajobs #pharmaceuticalindustry #USFDA #tatacapital #oppi #ongc Immunic Therapeutics I-Mab Biopharma Abbott Kura Oncology, Inc. Mirati Therapeutics Bayer Kokilaben Dhirubhai Ambani Hospital Akums Drugs& Pharmaceuticals Ltd

🌍💊🌟We're excited to be at DCAT Week showcasing our differentiated portfolio for global markets. 🤝Bluepharma team is represented by Sergio Simoes, Tobias Silva and Marcos Taveira Monteiro. Let's connect and unlock new possibilities together! 🔬👨🔬Discover how our integrated CRDMO services can accelerate your complex generics & innovator project development. Explore our strategic partnerships for complex generics!! 📩✍Want to schedule a meeting? Contact us [email protected] #DCATWeek #Bluepharma #Innovation #ComplexGenerics #pharmaceuticals #Portugal #USA #Bluepharma #careers #opportunities #witheyesetonthefuture #followbluepharma #Bluepharma #Bluepharma23anos #pharmaceuticalindustry #pharmaceutical #industry #indústriafarmacêutica #innovation #development #technology #health #pharmaceuticals #generics #CRDMO #CDMO #CMO #complexinjectabels  #highpotentproducts #Pharma #lifescience #oncology #research #pharma

Shout out to Eli Lilly and Company who secured its position in the top 10 for both innovation and invention, climbing two places on the Innovation Index (4th place) while experiencing a three-place decline on the Invention Index (7th place). Financially, the company saw a significant increase in revenue, accompanied by a nearly 30% boost in R&D spending. Additionally, Jardiance (empagliflozin), one of Lilly's flagship Type 2 diabetes products, garnered new indications for chronic kidney disease and symptomatic chronic heart failure regardless of ejection fraction. The company achieved significant milestones in its pipeline, with positive Phase 3 results for donanemab for Alzheimer’s disease. It also initiated Phase 3 studies for retatrutide, a triple hormone receptor agonist of GLP-1, glucose-dependent insulinotropic polypeptide (GIP) and glucagon receptors (GCGR), and for orforglipron, a non-peptide GLP-1 receptor agonist. Read the full analysis at https://lnkd.in/ei3fjshR #pharmaceutical #innovation #PIII2024

Great to have you at euroPLX 85 Dublin José Miguel Dias, Gonçalo Rocha and Bluepharma. #europlx #raucon #businessdevelopment #business #development #event #sales #events #tips #tip #partnering #success #pro #networking #network #pharma #pharmaceutical #opportunities #businessopportunities #networkingevent #benchmark